95 related articles for article (PubMed ID: 22907377)
1. Recombinant immunotoxins with low endotoxins for clinical and animal studies.
Onda M
Methods Mol Biol; 2012; 907():627-43. PubMed ID: 22907377
[TBL] [Abstract][Full Text] [Related]
2. Production of recombinant serpins in Escherichia coli.
Pearce MC; Cabrita LD
Methods Enzymol; 2011; 501():13-28. PubMed ID: 22078528
[TBL] [Abstract][Full Text] [Related]
3. Refolding of TIMP-2 from Escherichia coli inclusion bodies.
Williamson RA
Methods Mol Biol; 2010; 622():111-21. PubMed ID: 20135279
[TBL] [Abstract][Full Text] [Related]
4. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
[TBL] [Abstract][Full Text] [Related]
5. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
Bera TK; Pastan I
Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
[TBL] [Abstract][Full Text] [Related]
6. L-cysteine-enhanced renaturation of bioactive soluble tumor necrosis factor ligand family member LIGHT from inclusion bodies in Escherichia coli.
Tsuji I; Mastui H; Ito T; Kurokawa T; Shintani Y
Protein Expr Purif; 2011 Dec; 80(2):239-45. PubMed ID: 21745574
[TBL] [Abstract][Full Text] [Related]
7. Rational recombinant XMRV antigen preparation and bead coupling for multiplex serology in a suspension array.
Sheikholvaezin A; Blomberg F; Ohrmalm C; Sjösten A; Blomberg J
Protein Expr Purif; 2011 Dec; 80(2):176-84. PubMed ID: 21871964
[TBL] [Abstract][Full Text] [Related]
8. Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation.
Premsukh A; Lavoie JM; Cizeau J; Entwistle J; MacDonald GC
Protein Expr Purif; 2011 Jul; 78(1):27-37. PubMed ID: 21421055
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies.
McConnell MJ; Pachón J
Protein Expr Purif; 2011 May; 77(1):98-103. PubMed ID: 21130880
[TBL] [Abstract][Full Text] [Related]
10. Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cells.
Nand KN; Gupta JC; Panda AK; Jain SK
Protein Expr Purif; 2015 Feb; 106():10-7. PubMed ID: 25448825
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates.
Cavallaro AS; Mahony D; Commins M; Mahony TJ; Mitter N
Microb Cell Fact; 2011 Jul; 10():57. PubMed ID: 21787435
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture.
Francisco JA; Gawlak SL; Miller M; Bathe J; Russell D; Chace D; Mixan B; Zhao L; Fell HP; Siegall CB
Bioconjug Chem; 1997; 8(5):708-13. PubMed ID: 9327135
[TBL] [Abstract][Full Text] [Related]
13. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
[TBL] [Abstract][Full Text] [Related]
14. Production of functional inclusion bodies in endotoxin-free Escherichia coli.
Rueda F; Cano-Garrido O; Mamat U; Wilke K; Seras-Franzoso J; García-Fruitós E; Villaverde A
Appl Microbiol Biotechnol; 2014 Nov; 98(22):9229-38. PubMed ID: 25129611
[TBL] [Abstract][Full Text] [Related]
15. The delta-endotoxin proteins accumulate in Escherichia coli as a protein-DNA complex that can be dissociated by hydrophobic interaction chromatography.
Chaturvedi R; Bhakuni V; Tuli R
Protein Expr Purif; 2000 Oct; 20(1):21-6. PubMed ID: 11035946
[TBL] [Abstract][Full Text] [Related]
16. Purification of clinical-grade disulfide stabilized antibody fragment variable--Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli.
Jiang H; Xie Y; Burnette A; Roach J; Giardina SL; Hecht TT; Creekmore SP; Mitra G; Zhu J
Appl Microbiol Biotechnol; 2013 Jan; 97(2):621-32. PubMed ID: 22890777
[TBL] [Abstract][Full Text] [Related]
17. Renaturated ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active.
Tonevitsky A; Toptygin A; Agapov I; Pfueller U; Frankel A
Biochem Mol Biol Int; 1994 Apr; 32(6):1139-46. PubMed ID: 8061631
[TBL] [Abstract][Full Text] [Related]
18. High-level expression, purification, and renaturation of recombinant murine interleukin-2 from Escherichia coli.
Guisez Y; Demolder J; Mertens N; Raeymaekers A; Plaetinck G; Robbens J; Vandekerckhove J; Remaut E; Fiers W
Protein Expr Purif; 1993 Jun; 4(3):240-6. PubMed ID: 8390881
[TBL] [Abstract][Full Text] [Related]
19. Expanded bed adsorption for recovery of renatured human recombinant interleukin 8 from Escherichia coli inclusion bodies.
Barnfield Frej AK
Bioseparation; 1996; 6(5):265-71. PubMed ID: 9210348
[TBL] [Abstract][Full Text] [Related]
20. Development and scale-up of a commercial fed batch refolding process for an anti-CD22 two chain immunotoxin.
Linke T; Aspelund MT; Thompson C; Xi G; Fulton A; Wendeler M; Pabst TM; Wang X; Wang WK; Ram K; Hunter AK
Biotechnol Prog; 2014; 30(6):1380-9. PubMed ID: 25139260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
